Clin2
NCT06188234Likely a fitRecruiting

Tenero diabetes medication study for adults with type 2 diabetes

Diabetes Mellitus, Type 2

Part of Hormones & metabolism clinical trials.

This study looks at how doctors prescribe Tenero Tab or Tenero M SR Tab for adults with type 2 diabetes and how well the medication works. It is for people who are starting this treatment for the first time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
19 years and older
Study type
Observational

Who can take part

  • You are 19 years of age or older.
  • You have been diagnosed with type 2 diabetes.
  • Your doctor has decided to prescribe Tenero Tab or Tenero M SR Tab for your diabetes for the first time.
  • You are willing to give written permission to be in the study.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07248891Enrolling by invitation
Type 2 diabetes study in Mexico

This study looks at factors related to type 2 diabetes in adults receiving care at family medicine clinics in three Mexican states. It may help improve understanding of diabetes management.

Mexico City, Mexico City
NCT07245082Recruiting
Type 2 diabetes patient study

This study looks at people with type 2 diabetes to understand their health. If you join, you'll have simple measurements taken like height, weight, and grip strength.

Taipei, Zhongzheng Dist
NCT07308184Not yet recruiting· Phase 3
Study of a new diabetes injection for type 2 diabetes

This study is testing a new injectable medication (IN-B00009) to see if it helps lower blood sugar in people with type 2 diabetes who are not currently on diabetes medicine. It might be an option if diet and exercise alone are not enough to control your diabetes.

NCT07570992Recruiting· Phase 1
Safety study of NNC1679-0001 in healthy people and people with type 2 diabetes

This study tests the safety of a new medicine called NNC1679-0001 in healthy adults and those with type 2 diabetes. The goal is to see if it is safe before larger trials.

Graz
NCT07193459Recruiting· Phase 3
Study of an oral tablet for type 2 diabetes

This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.

Beijing, Beijing Municipality
NCT07599410Recruiting· Phase 2
Testing HRS9531 for Type 2 Diabetes Blood Sugar Control

This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.

Beijing, Beijing Municipality

Hear when a new Diabetes Mellitus, Type 2 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.